Dr. Gerard B. Agbulos, MD

Dr. Agbulos practices at Centennial Hills Hospital Medical Center in Las Vegas, Nevada.

Dr. Agbulos' NPI, 1700191053, was assigned on August 11, 2010. Dr. Agbulos holds Florida license ME107948.

Dr. Agbulos' primary practice is Centennial Hills Hospital Medical Center, at 6901 N Durango Dr, Las Vegas, NV 89149 in Clark County. The practice phone is (702) 894-5706.

Dr. Agbulos' primary practice is Centennial Hills Hospital Medical Center in Las Vegas, Nevada. Dr. Agbulos is also affiliated with Centennial Hills Hospital Medical Center. The medical group on file is Platinum Hospitalists. Dmand AI also links Dr. Agbulos to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agbulos practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Agbulos' primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Agbulos' licenses on file in 3 states: Florida, Nebraska and New York.

CMS data shows 988 Medicare services from Dr. Agbulos across 5 procedure codes in 2024, for 617 Medicare patients. Medicare paid $103,320 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 617 Medicare patients who saw Dr. Agbulos in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agbulos' median patient age at 68, with 51% women.

In 2024, Dr. Agbulos wrote 77 Medicare Part D claims for 38 patients. 86% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $87 in total drug cost. In 2022, CMS named 58 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 62 out of 100 for Dr. Agbulos for performance year 2024, reported individually. Dr. Agbulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. Agbulos from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $118.